Research Paper Volume 12, Issue 11 pp 10983—11003

The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis

class="figure-viewer-img"

Figure 8. CD44 is directly targeted by miR-520b-3p and regulated by circIFI30. (A) Schematic illustration of CD44 3’UTR-WT and CD44 3’UTR-Mut luciferase reporter vectors was shown. (B) Luciferase reporter assay demonstrated that CD44 is direct target of miR-520b-3p. (C, D) Relative mRNA and protein levels of CD44 were detected after TNBC cells were transfected with miR-520b-3p mimics or inhibitors using qRT-PCR and western blot, respectively. (E) Pearson correlation analysis between the expression of circIFI30 and CD44 was shown in 38 TNBC tissues. (F) Relative expression of CD44 was detected by qRT-PCR in cells transfected with indicated vectors, miR-520b-3p or inhibitors. (G) The schematic diagram illustrates how circifi30 might promote EMT, tumorigenesis and metastasis of TNBC through circIFI30/miR-520b-3p/CD44 axis. Data were indicated as mean ± SD, *P < 0.05, **P < 0.01, ***P < 0.001.